Over the last 7 days, the Pharma industry has remained flat. As for the the longer term, the industry is up 51% over the past 12 months. Earnings are forecast to grow by 17% annually.
Has the Indian Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Wed, 17 Jul 2024 | ₹18.8t | ₹3.6t | ₹449.9b | 34.7x | 41.7x | 5.2x |
Fri, 14 Jun 2024 | ₹17.6t | ₹3.6t | ₹448.3b | 33x | 39.3x | 4.9x |
Sun, 12 May 2024 | ₹16.7t | ₹3.5t | ₹428.7b | 33.4x | 39x | 4.8x |
Tue, 09 Apr 2024 | ₹17.2t | ₹3.5t | ₹418.9b | 33.5x | 41.1x | 4.9x |
Thu, 07 Mar 2024 | ₹17.0t | ₹3.5t | ₹418.7b | 33x | 40.7x | 4.9x |
Sat, 03 Feb 2024 | ₹16.1t | ₹3.4t | ₹405.3b | 34.6x | 39.8x | 4.7x |
Mon, 01 Jan 2024 | ₹15.0t | ₹3.4t | ₹395.9b | 34.1x | 37.8x | 4.4x |
Wed, 29 Nov 2023 | ₹14.0t | ₹3.4t | ₹395.1b | 31x | 35.5x | 4.1x |
Fri, 27 Oct 2023 | ₹12.7t | ₹3.3t | ₹368.8b | 28x | 34.4x | 3.9x |
Sun, 24 Sep 2023 | ₹12.9t | ₹3.3t | ₹369.5b | 29.7x | 35x | 4x |
Tue, 22 Aug 2023 | ₹13.0t | ₹3.3t | ₹367.1b | 28.8x | 35.5x | 4x |
Thu, 20 Jul 2023 | ₹12.1t | ₹3.2t | ₹342.6b | 26.2x | 35.3x | 3.8x |
Sat, 17 Jun 2023 | ₹11.4t | ₹3.2t | ₹342.4b | 27.1x | 33.2x | 3.6x |
Mon, 15 May 2023 | ₹10.5t | ₹3.1t | ₹309.4b | 27x | 33.9x | 3.4x |
Wed, 12 Apr 2023 | ₹9.8t | ₹3.0t | ₹277.5b | 25.6x | 35.3x | 3.3x |
Fri, 10 Mar 2023 | ₹9.4t | ₹3.0t | ₹277.5b | 23.5x | 33.7x | 3.1x |
Sun, 05 Feb 2023 | ₹9.7t | ₹2.9t | ₹283.6b | 24.4x | 34x | 3.3x |
Tue, 03 Jan 2023 | ₹9.9t | ₹2.9t | ₹274.9b | 26.9x | 35.9x | 3.5x |
Thu, 01 Dec 2022 | ₹10.2t | ₹2.9t | ₹274.9b | 26.5x | 37.2x | 3.6x |
Sat, 29 Oct 2022 | ₹10.2t | ₹2.8t | ₹259.4b | 24.1x | 39.2x | 3.6x |
Mon, 26 Sep 2022 | ₹9.7t | ₹2.8t | ₹261.9b | 23.5x | 36.9x | 3.5x |
Wed, 24 Aug 2022 | ₹9.7t | ₹2.8t | ₹261.9b | 22.5x | 37x | 3.5x |
Fri, 22 Jul 2022 | ₹9.7t | ₹2.7t | ₹273.4b | 22.3x | 35.3x | 3.6x |
Sun, 19 Jun 2022 | ₹8.9t | ₹2.8t | ₹273.8b | 20.4x | 32.5x | 3.2x |
Tue, 17 May 2022 | ₹9.3t | ₹2.7t | ₹333.7b | 21.1x | 27.9x | 3.4x |
Thu, 14 Apr 2022 | ₹10.2t | ₹2.7t | ₹338.0b | 24.3x | 30.3x | 3.8x |
Sat, 12 Mar 2022 | ₹9.9t | ₹2.7t | ₹337.9b | 23.4x | 29.4x | 3.7x |
Mon, 07 Feb 2022 | ₹10.2t | ₹2.7t | ₹369.6b | 25.1x | 27.7x | 3.8x |
Wed, 05 Jan 2022 | ₹10.7t | ₹2.7t | ₹360.6b | 26.1x | 29.7x | 4x |
Fri, 03 Dec 2021 | ₹10.2t | ₹2.7t | ₹360.3b | 22.4x | 28.2x | 3.8x |
Sun, 31 Oct 2021 | ₹10.4t | ₹2.6t | ₹363.0b | 23.4x | 28.6x | 3.9x |
Tue, 28 Sep 2021 | ₹10.8t | ₹2.6t | ₹375.7b | 25.6x | 28.6x | 4.1x |
Thu, 26 Aug 2021 | ₹10.6t | ₹2.6t | ₹375.2b | 23.3x | 28.2x | 4.1x |
29.6x
Which industries have driven the changes within the Indian Healthcare industry?
IN Market | 0.82% | |
Healthcare | 0.73% | |
Pharma | 0.75% | |
Pharma | 0.75% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
AUROPHARMA Aurobindo Pharma | ₹1.37k | 2.9% +₹22.6b | 82.1% | PE25.3x | |
APLLTD Alembic Pharmaceuticals | ₹1.08k | 11.3% +₹21.6b | 64.4% | PE34.6x | |
ZYDUSLIFE Zydus Lifesciences | ₹1.18k | 1.7% +₹19.5b | 96.8% | PE31.1x | |
NATCOPHARM NATCO Pharma | ₹1.28k | 6.8% +₹14.6b | 79.6% | PE16.5x | |
GLENMARK Glenmark Pharmaceuticals | ₹1.41k | 3.8% +₹14.6b | 95.6% | PS3.4x |